Neurology · Cranial Nerve Disorders
The facts most likely to be tested
Press 1–5 to rate · ↑↓ to navigate
Trigeminal neuralgia presents as unilateral, paroxysmal, lancinating, or electric shock-like pain in the distribution of the trigeminal nerve (CN V).
The most common etiology is vascular compression of the trigeminal nerve root, typically by the superior cerebellar artery.
Pain is classically triggered by innocuous stimuli such as chewing, brushing teeth, washing the face, or exposure to cold air.
Carbamazepine is the first-line pharmacological treatment for trigeminal neuralgia.
Patients with bilateral trigeminal neuralgia or those with sensory deficits on physical exam must be evaluated for multiple sclerosis or a cerebellopontine angle tumor.
Oxcarbazepine is an alternative first-line agent that is often preferred due to a more favorable side effect profile compared to carbamazepine.
Microvascular decompression is the definitive surgical intervention for patients who are refractory to medical therapy or cannot tolerate medication side effects.
Vignette unlocked
A 62-year-old woman presents to the clinic complaining of recurrent, severe, stabbing pain on the right side of her face. She describes the pain as an electric shock that lasts for seconds and is triggered by brushing her teeth or eating. Physical examination reveals normal facial sensation and no motor deficits. She has no history of trauma or recent dental procedures. Her symptoms are currently well-controlled with a medication that requires monitoring for agranulocytosis and hyponatremia.
What is the most likely diagnosis and the mechanism of the underlying pathology?
Trigeminal neuralgia caused by vascular compression of the trigeminal nerve root.
The vignette describes the classic presentation of trigeminal neuralgia (Bet 1) and identifies the first-line treatment, carbamazepine (Bet 4), which is associated with the side effects mentioned.
Full handout
High yield triage
Etiology / Epidemiology
Common in women >50 years old; typically caused by vascular compression of the trigeminal nerve root.
Clinical Manifestations
Unilateral stabbing, electric-shock-like pain in the V2/V3 distribution triggered by light touch.
Diagnosis
Clinical diagnosis; MRI of the brain is the gold standard to rule out secondary causes like tumors or MS.
Treatment
Carbamazepine is the first-line treatment; monitor for agranulocytosis.
Prognosis
Chronic condition with remitting-relapsing course; surgical decompression is curative for refractory cases.
Full handout
Epidemiology & Etiology
Incidence increases with age, most commonly presenting in the 5th-7th decades. Primary etiology is neurovascular compression by the superior cerebellar artery. Secondary causes include multiple sclerosis, cerebellopontine angle tumors, or structural lesions.
Pertinent Anatomy
The trigeminal nerve (CN V) provides sensory innervation to the face. The maxillary (V2) and mandibular (V3) branches are most frequently involved in neuralgic pain.
Pathophysiology
Chronic pulsatile compression leads to focal demyelination of the nerve root. This creates an environment of ephaptic transmission, where adjacent nerve fibers cross-talk. This results in hyper-excitability and the characteristic paroxysmal pain response to innocuous stimuli.
Clinical Manifestations
Patients report sudden, severe, unilateral facial pain described as lightning-like or stabbing. Attacks are triggered by non-painful stimuli like chewing, brushing teeth, or cold wind. Red flags include sensory loss, bilateral involvement, or onset in patients <40 years old, which mandate investigation for multiple sclerosis.
Diagnosis
Diagnosis is primarily clinical based on the classic history. MRI with and without contrast (or MRA) is the gold standard to visualize neurovascular conflict and exclude structural pathology. No specific laboratory thresholds exist, but baseline CBC is required before starting therapy.
Treatment
Carbamazepine is the first-line pharmacological agent. Agranulocytosis and Stevens-Johnson syndrome are critical adverse effects requiring monitoring. Refractory cases may require microvascular decompression or rhizotomy.
Prognosis
Most patients achieve significant relief with medication, though many experience a relapsing-remitting course. Long-term management requires monitoring for bone marrow suppression and hepatotoxicity in patients on chronic anticonvulsant therapy.
Differential Diagnosis
Temporomandibular joint disorder: pain associated with jaw movement/clicking
Glossopharyngeal neuralgia: pain localized to the throat/ear/tonsillar fossa
Multiple sclerosis: associated with bilateral symptoms and sensory deficits
Cluster headache: associated with autonomic symptoms like lacrimation/rhinorrhea
Dental abscess: constant, throbbing pain with localized swelling/fever